Drug Profile
PD 156707
Alternative Names: CI 1020Latest Information Update: 07 Jun 2013
Price :
$50
*
At a glance
- Originator Pfizer
- Class Anti-ischaemics; Antihypertensives; Dioxoles
- Mechanism of Action Endothelin A receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cerebral ischaemia; Heart failure; Myocardial ischaemia; Pulmonary hypertension